Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFP Block for Post-Cesarean Analgesia
NCT03236324Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Sep 2017
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by University of Calgary. Primary endpoint: Postoperative opioid consumption at 24 hours. Started Sep 2017; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03236324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03236324.